Pitfalls in neuroendocrine tumor diagnosis

por Bajetta, Emilio, Platania, Marco
Publicado 2009

Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron

por Bajetta, Emilio, Pusceddu, Sara, Guadalupi, Valentina, Ducceschi, Monika, Celio, Luigi
Publicado 2009

Common Diagnostic Challenges in the Histopathologic Diagnosis of Neuroendocrine Lung Tumors: A Case Report

por Valente, Monica, Catena, Laura, Milione, Massimo, Pusceddu, Sara, Formisano, Barbara, Bajetta, Emilio
Publicado 2010

Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: meta-analysis of in...

por Celio, Luigi, Bonizzoni, Erminio, Bajetta, Emilio, Sebastiani, Silvia, Perrone, Tania, Aapro, Matti S.
Publicado 2012

Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement

por Dottorini, Lorenzo, Catena, Laura, Sarno, Italo, Di Menna, Giandomenico, Marte, Annamaria, Bajetta, Emilio
Publicado en Oncology (2018)

Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

por Castellano, Daniel, Bajetta, Emilio, Panneerselvam, Ashok, Saletan, Stephen, Kocha, Walter, O'Dorisio, Thomas, Anthony, Lowell B., Hobday, Timothy
Publicado 2013

Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis

por Strosberg, Jonathan R, Yao, James C, Bajetta, Emilio, Aout, Mounir, Bakker, Bert, Hainsworth, John D, Ruszniewski, Philippe B, Van Cutsem, Eric, Öberg, Kjell, Pavel, Marianne E
Publicado en Endocr Relat Cancer (2015)

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, pha...

por Celio, Luigi, Frustaci, Sergio, Denaro, Angela, Buonadonna, Angela, Ardizzoia, Antonio, Piazza, Elena, Fabi, Alessandra, Capobianco, Alba Maria, Isa, Luciano, Cavanna, Luigi, Bertolini, Alessandro, Bichisao, Ettore, Bajetta, Emilio
Publicado 2010

Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens

por Martinetti, Antonia, Miceli, Rosalba, Sottotetti, Elisa, Di Bartolomeo, Maria, de Braud, Filippo, Gevorgyan, Arpine, Dotti, Katia Fiorella, Bajetta, Emilio, Campiglio, Manuela, Bianchi, Francesca, Bregni, Giacomo, Pietrantonio, Filippo
Publicado 2014

Phase II Study of Everolimus in Patients With Metastatic Colorectal Adenocarcinoma Previously Treated With Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regim...

por Ng, Kimmie, Tabernero, Josep, Hwang, Jimmy, Bajetta, Emilio, Sharma, Sunil, Del Prete, Salvatore A., Arrowsmith, Edward R., Ryan, David P., Sedova, Michaela, Jin, Jin, Malek, Kamel, Fuchs, Charles S.
Publicado 2013

The cost of unresectable stage III or stage IV melanoma in Italy

por Maio Michele, Ascierto Paolo, Testori Alessandro, Ridolfi Ruggero, Bajetta Emilio, Queirolo Paola, Guida Michele, Romanini Antonella, Chiarion-Sileni Vanna, Pigozzo Jacopo, Di Giacomo Anna Maria, Calandriello Mario, Didoni Guido, van Baardewijk Marck, Konto Cyril, Lucioni Carlo
Publicado 2012-11-01

The cost of unresectable stage III or stage IV melanoma in Italy

por Maio, Michele, Ascierto, Paolo, Testori, Alessandro, Ridolfi, Ruggero, Bajetta, Emilio, Queirolo, Paola, Guida, Michele, Romanini, Antonella, Chiarion-Sileni, Vanna, Pigozzo, Jacopo, Di Giacomo, Anna Maria, Calandriello, Mario, Didoni, Guido, van Baardewijk, Marck, Konto, Cyril, Lucioni, Carlo
Publicado 2012

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme

por Altomonte, Maresa, Di Giacomo, Anna Maria, Queirolo, Paola, Ascierto, Paolo Antonio, Spagnolo, Francesco, Bajetta, Emilio, Calabrò, Luana, Danielli, Riccardo, de Rosa, Francesco, Maur, Michela, Chiarion-Sileni, Vanna, Ferrucci, Pier Francesco, Giannarelli, Diana, Testori, Alessandro, Ridolfi, Ruggero, Maio, Michele
Publicado 2013

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors

por Pusceddu, Sara, Barretta, Francesco, Trama, Annalisa, Botta, Laura, Milione, Massimo, Buzzoni, Roberto, De Braud, Filippo, Mazzaferro, Vincenzo, Pastorino, Ugo, Seregni, Ettore, Mariani, Luigi, Gatta, Gemma, Di Bartolomeo, Maria, Femia, Daniela, Prinzi, Natalie, Coppa, Jorgelina, Panzuto, Francesco, Antonuzzo, Lorenzo, Bajetta, Emilio, Brizzi, Maria Pia, Campana, Davide, Catena, Laura, Comber, Harry, Dwane, Fiona, Fazio, Nicola, Faggiano, Antongiulio, Giuffrida, Dario, Henau, Kris, Ibrahim, Toni, Marconcini, Riccardo, Massironi, Sara, Žakelj, Maja Primic, Spada, Francesca, Tafuto, Salvatore, Van Eycken, Elizabeth, Van der Zwan, Jan Maaten, Žagar, Tina, Giacomelli, Luca, Miceli, Rosalba, Aroldi, Francesca, Bongiovanni, Alberto, Berardi, Rossana, Brighi, Nicole, Cingarlini, Sara, Cauchi, Carolina, Cavalcoli, Federica, Carnaghi, Carlo, Corti, Francesca, Duro, Marilina, Davì, Maria Vittoria, De Divitiis, Chiara, Ermacora, Paola, La Salvia, Anna, Luppi, Gabriele, Lo Russo, Giuseppe, Nichetti, Federico, Raimondi, Alessandra, Perfetti, Vittorio, Razzore, Paola, Rinzivillo, Maria, Siesling, Sabine, Torchio, Martina, Van Dijk, Boukje, Visser, Otto, Vernieri, Claudio
Publicado en Endocr Relat Cancer (2018)